NI
ARRY

Numeric Investors’s Array Biopharma Inc ARRY Stock Holding History

Numeric Investors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,500
Closed -$240K – 1249
2017
Q3 		$240K Buy
+19,500
New +$181K ﹤0.01% 1011
2016
Q3 		– Sell
-71,000
Closed -$253K – 1268
2016
Q2 		$253K Sell
71,000
-80,700
-53% -$263K ﹤0.01% 919
2016
Q1 		$448K Sell
151,700
-42,900
-22% -$129K ﹤0.01% 739
2015
Q4 		$821K Buy
194,600
+160,500
+471% +$732K 0.01% 619
2015
Q3 		$155K Buy
34,100
+9,500
+39% +$56.3K ﹤0.01% 941
2015
Q2 		$177K Buy
24,600
+6,400
+35% +$47.2K ﹤0.01% 875
2015
Q1 		$134K Sell
18,200
-16,900
-48% -$120K ﹤0.01% 847
2014
Q4 		$166K Buy
35,100
+24,500
+231% +$96.9K ﹤0.01% 798
2014
Q3 		$38K Buy
+10,600
New +$41.8K ﹤0.01% 794
2014
Q1 		– Sell
-295,406
Closed -$1.48M – 949
2013
Q4 		$1.48M Sell
295,406
-124,986
-30% -$680K 0.02% 396
2013
Q3 		$2.62M Sell
420,392
-151,499
-26% -$900K 0.05% 301
2013
Q2 		$2.6M Buy
+571,891
New +$3.08M 0.05% 278

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Numeric Investors's ARRY Position: Q4 2017 in Review

Numeric Investors sold out of Array Biopharma Inc (ARRY) in Q4 2017, closing a stake of 19,500 shares — an estimated $240K sold.

Numeric Investors first reported a position in ARRY in Q2 2013 and held it in 12 quarters. The position peaked at $2.62M in Q3 2013. 191 funds tracked by Wall St. Rank hold ARRY as of Q4 2017.

  • Numeric Investors reported no remaining Array Biopharma Inc position as of Q4 2017 after selling out during the quarter.
  • Numeric Investors sold 19,500 Array Biopharma Inc shares in Q4 2017, an estimated $240K.
  • Numeric Investors first reported a position in Array Biopharma Inc in Q2 2013 and held it in 12 quarters.
  • Numeric Investors's Array Biopharma Inc position peaked at $2.62M in Q3 2013.
  • 191 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.